As of 2025-12-22, the Relative Valuation of ImmunoGen Inc (IMGN) is (4.67) USD. This relative valuation is based on P/E multiples. With the latest stock price at 31.23 USD, the upside of ImmunoGen Inc based on Relative Valuation is -115.0%.
The range of the Relative Valuation is (3.84) - (5.43) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 14.4x - 20.6x | 17.6x |
| Forward P/E multiples | 14.6x - 25.1x | 17.9x |
| Fair Price | (3.84) - (5.43) | (4.67) |
| Upside | -112.3% - -117.4% | -115.0% |
| Date | P/E |